RECOVER Study on Long COVID: Virtual Town Hall Recap
ISB hosted a virtual event to share updates on the ongoing RECOVER study, a national NIH-funded initiative to understand and address Long COVID.
Back to Previous Page
Posts
COVID and Long COVID
-
- All Categories
- Autoimmune Diseases
- Awards
- Cancer
- Chronic Illness
- COVID and Long COVID
- Education
- Events
- Hadlock Lab
- Hands-on Learning
- Health
- Health Data Science Lab
- Health Equity
- Heath Lab
- Hood Lab
- Infectious Disease
- ISB-Town Hall
- Logan Center for Education
- Optimizing Outcomes
- People
- Philanthropy
- Precision Treatments
- Press Release
- Real-world Science
- Research Roundtable
- Subramanian Lab
- Systemic Change
- Understanding Tumors
Sort
-
- Default
- A-Z
- Z-A
- Newest
- Oldest
Understanding, Preventing and Treating Long-Term Effects of COVID: RECOVER Study Enrolling Patients from Pacific Northwest
As part of a massive nationwide effort, ISB is leading a multi-site consortium for the NIH RECOVER (Researching COVID to Enhance Recovery) Initiative. The Pacific Northwest consortium is made up of ISB, Providence, Swedish, and University of Washington School of Medicine.
Predicting ‘Long COVID’ At Initial Point of COVID-19 Diagnosis
Researchers have identified several factors that can be measured at the initial point of COVID-19 diagnosis that anticipate if a patient is likely to develop long COVID. They also found that mild cases of COVID-19, not just severe cases, are associated with long COVID. Their findings were published by the journal Cell.
Research Roundtable with Dr. Jim Heath on COVID
On January 18, 2022, Dr. Jim Heath gave a talk on COVID at the first Research Roundtable event of 2022. Research Roundtable is a series of ISB hosted conversations with our leading scientists on the latest research happening at ISB. Designed for a lay audience, this series is open to all. Attendees have the opportunity to ask questions directly to our scientists.
Metabolic Changes in Plasma and Immune Cells Associated with COVID-19 Severity, May Predict Patient Survival
Researchers from Institute for Systems Biology (ISB), Fred Hutchinson Cancer Research Center and other organizations have uncovered underlying metabolic changes that regulate how immune cells react to COVID-19. These findings are associated with COVID-19 severity and may predict patient survival. The work was published in the journal Nature Biotechnology.
COVID-19 Outcome Disparities Across Racial/Ethnic Lines
ISB researchers and their collaborators looked at the electronic health records of nearly 630,000 patients who were tested for SARS-CoV-2, and found stark disparities in COVID-19 outcomes — odds of infection, hospitalization, and in-hospital mortality — between White and non-White minority racial and ethnic groups.